About The Pharma Letter
The Pharma Letter provides accurate, unbiased business information on the worldwide pharmaceutical, generic and biotechnology industries.
Thousands of executives in these and allied organisations find The Pharma Letter a necessary read to keep them the first to know about current news and events, written whilst the news is fresh and has the greatest impact on commercial decisions.
Save time and effort with authoritative, analysed and unbiased news delivered to you daily online straight to your screen, together with e-mail alerts and full access to The Pharma Letter's searchable archive from 1991.
- Company news. Financial reports, marketing developments, trends and strategies, corporate development, company profiles, legal influences, R&D trends, M&A activity, sales performance, stock market analyses and personnel appointments.
- Product news. Drug submissions, approvals and rejections, licensing arrangements, clinical trial developments and results, product development and new product introductions.
- European, USA and world news. Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details and write-ups.
Barbara Obstoj-Cardwell is the managing editor of The Pharma Letter, which in 2009 acquired the archives of The Pharma Marketletter, a publication that Barbara owned since 1991 and prior to that edited when it was part of IMS Health. Barbara was also the founding editor of Scrip World Pharmaceutical News, and has an extensive and long-term knowledge of the global pharmaceutical industry and its players.
Barbara is supported by a world-wide network of correspondents and medical writers.
We hope that you enjoy our publication!